Pacific Biosciences of California (PACB) earnings · rev $160.0M
These earnings events as JSON? API free 100/dayPacific Biosciences of California (PACB) is a medical devices company listed on US.
This PACB earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported PACB revenue for 2025-12-31 was $160.0M. Net income was -$546.4M. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. PACB currently screens at market cap $387.1M.
When the next PACB 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 3.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full PACB research stays on the stock page; the tape stays on the quote page.
PACB earnings FAQ
What are PACB's latest revenue and net income?
Latest cached Pacific Biosciences of California (PACB) revenue for Dec 31, 2025 was $160.0M. Net income was -$546.4M. Statements: https://lician.com/financials/pacb
What is PACB's latest diluted EPS?
Latest cached Pacific Biosciences of California (PACB) diluted EPS for Dec 31, 2025 was -$1.82.
What period does the latest PACB earnings print cover?
The latest cached Pacific Biosciences of California (PACB) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did PACB revenue change from the prior cached period?
Cached Pacific Biosciences of California (PACB) revenue was up 3.9% from $154.0M (Dec 31, 2024) to $160.0M (Dec 31, 2025). Statements: https://lician.com/financials/pacb
Where are PACB earnings listed?
Cached earnings facts for Pacific Biosciences of California (PACB) are listed at https://lician.com/earnings/pacb. Statements: https://lician.com/financials/pacb
Not investment advice.